Fig. 2

LASS2 expression is correlated with clinical parameters and the prognosis of thyroid, breast, and liver cancer. A–C LASS2 expression in thyroid, breast, and liver cancer tissues is correlated with tumour size, lymph node metastasis, and clinical TNM stage (scale bar: 100/50 μm). D–F Public database analysis of survival differences between patients with high and low LASS2 expression in thyroid, breast, and liver cancers. *P < 0.05, **P < 0.01